ENTITY
Eisai Co Ltd

Eisai Co Ltd (4523 JP)

101
Analysis
Health CareJapan
Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.
more
Refresh
bullishEisai Co Ltd
06 Jul 2018 15:11

BAN2401Demonstrates Statistically Significant Clinical Data for 18 Months Study

We will review our numbers and rating after review of the full data at AAIC and for now maintain our “Equal-weight” rating on the...

bullishEisai Co Ltd
03 Jul 2018 20:11

Merck Alliance Provides Stability to Deal With the Outcome of High Risk Alzheimer’s R&D in FY19

We upgrade Eisai Co Ltd (4523 JP) to “Equal-weight” after reviewing our model post FY17 (YE Mar-18) earnings, in light of the augmented peak sales...

04 Jun 2018 08:47

Japan: Sectors/Peer Groups 3M🔺Too Early to Bottom-Fish Cyclicals •Time to Trim Personal Products

THREE-MONTH % CHANGE IN SECTORS & PEER GROUPS - This regular insight focuses on the percentage change in each sectors' weight in the market...

Logo
119 Views
Share
bearishEisai Co Ltd
17 May 2018 19:14

Eisai FY17 Earnings - First Glance

Eisai Co Ltd (4523 JP) reported FY17 results on May 15, 2018 Lenvima sales ramp-up + Upfront payment from Merck led FY17 topline growth and gross...

x